On May 24, Eastern Time, many Wall Street banks updateddurantsquarebingo$Legendary Creature (LEGNdurantsquarebingo.US)$, with target prices ranging from $60 to $94.
Furui Group analyst Kelly Shi maintains a buy rating and maintains a target price of US$94.
BMO Capital Markets analyst Kostas Biliouris maintains a buy rating and maintains a target price of $90.
Deutsche Numis analyst James Shin gives the first buy rating with a target price of $60.
H.C. Wainwright analyst Mitchell Kapoor maintained a buy rating and lowered his price target to $73 from $86.
The following are the latest investment ratings and target prices of four analysts for $Legendary Biotech (LEGN.US)$todaydurantsquarebingo：
promptdurantsquarebingo:
TipRanks is an independent third party that provides analytical data from financial analysts and calculates the average rate of return and winning percentage recommended by the analysts. The information provided is not investment advice and is for reference only. This document does not endorse, represent or warrant the completeness or accuracy of rating data and reports.
TipRanks provides each analyst's star rating. The analyst star rating represents all the analyst's recommended past performance. Through a comprehensive calculation of the analyst's total winning rate and average return rate, the more stars there are, the better the analyst's past performance, with a maximum of 5 stars.
The total analyst win rate is the ratio of the number of rating successes by analysts to the total number of ratings in the past year. The success of the rating depends on whether TipRanks 'virtual portfolio generates positive returns from the stock.
The total average rate of return is the rate of return obtained by a virtual portfolio created based on the analyst's initial rating and adjusted for rating changes in the past year.